The Moroccan Agency for Medicines and Health Products (AMMPS) has recently approved the national market release of Ozempic for the treatment of type 2 diabetes. Currently, only the expensive brand-name version of this injectable medication, which contains semaglutide, is available. The Association for Access to Treatment (ITPC-MENA) has approached the agency to advocate for the availability of affordable generic versions, emphasizing that their use should not be misappropriated.
A PhD in Molecular and Cellular Biology based in the United States, Moroccan Abdelfattah El Ouaamari is fascinated with biochemistry. This passion led him to a special field of research, linked to diabetes. Currently Assistant Professor at Rutgers University in New Jersey, he conducting his own research to understand this disease and thus achieve a cure, without resorting to insulin.
Sweet diet and diabetes : the alarm was sounded a few years ago, but Morocco chooses to look elsewhere. While in France the «soda tax» has been toughened up, in Morocco, the government still struggles to lift subsidies on the sugar bought by the soda industry.
According to the International Diabetes Federation’s recent statistics, Morocco is severely touched by diabetes. The numbers published on the Federation’s website indicate that 1.6 million Moroccans suffer from the disease. To generate awareness about it, the kingdom’s capital hosted last Saturday “Premix Summit”, around 250 experts reunited to exchange expertise and help with the management of the chronic disease.
Les articles les plus...
chargement...
